- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04848155
Measuring the Impact of a Socially Assistive Robot
Measuring the Impact of Socially Assistive Robot on Older Adults With MCI and Their Caregivers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of the current study is to evaluate the impact of the robot using a cross-over design.
- Recruitment An existing database with facilities, built up in the previous phases of the project, will be used to recruit new participants. Sample Size calculations were done a priori using G*Power, based on an effect size of 0.4 and testing the difference between two dependent means. According to these calculations, a total sample size of 62 would allow us to detect significant differences among the mean values on the primary outcome measures (α =.025 and power =.8).
- Handling Missing Data Since the reason for dropouts might be of great importance for the results of this study, they will be taken into account. Therefore, the Intention To Treat (ITT) approach will be applied.
Data Analysis
- Quantitative Analysis
Descriptive statistics will be employed to describe the characteristics of the participants. Distribution of data will be assessed by inspecting the histograms and by appropriate tests, e.g. Shapiro-Wilk Test. Data will be visualized using bar charts (categorical variables) and/or box plots (continuous variables). If appropriate, independent t-tests will be used at baseline data to investigate whether or not there are significant differences between both groups. Alternatively, in case of non-normal distributed data, Mann Whitney-U tests will be applied instead.
Active Engagement Evaluation will be performed at baseline, after 3 months, 6 months, 9 months and 12 months in the study with both group A and B. Primary endpoint is the comparison "no robot" vs "robot" at 6 months within that period. Active Engagement will be calculated by comparing the data of the intervention and control group after 6 months and 12 months with counts (the number of times the person shows a certain behavior at a certain time point during the activity) as the outcome variable. Data will be analyzed using a mixed negative binominal regression, with the subjects considered the random factor and the following variables as fixed effects: (1) condition (robot vs no robot), (2) time (baseline, 3 and 6 months) and (3) interaction between condition and time.
Loneliness Evaluation will be performed at baseline, after 3 months, 6 months, 9 months and 12 months in the study with both group A and B. Primary endpoint is the comparison "no robot" vs "robot" at 6 months within that period. Loneliness will be calculated by comparing the scores on the (full) loneliness scale of the intervention group and the control group after 6 and 12 months. Data will be analyzed using a mixed linear regression, with "loneliness" as the outcome variable and the following variables as fixed effects: (1) condition (robot vs no robot), (2) time (baseline, 3 and 6 months) and (3) interaction between condition and time. The subjects in the study are considered the random factor.
Secondary outcomes Evaluation will be performed at baseline, after 3 months, 6 months, 9 months and 12 months in the study with both group A and B. Primary endpoint is the comparison "no robot" vs "robot" at 6 months within that period. For analyzing the data of the secondary outcomes (physical functioning, cognitive functioning and participation), a linear mixed model will be used (similar to the primary outcomes) if data is distributed normally.
Since multiple comparisons are made, a Bonferroni correction will be applied. The Bonferroni-corrected level of statistical significance will be set at α = .025. Data analyses will be conducted by SPSS Statistics software. For the secondary outcomes, statistical significance will be set at a level of p<.05.
2 - Qualitative Analysis
Focus groups will be conducted after 6 and 12 months to receive feedback from the caregivers. Inductive thematic analysis will be used to analyze the data from the focus groups. This will be done according to the guideline designed by Braun and Clarke (2006), which describes different phases in the process of conducting thematic analysis. In the first phase, the researcher becomes familiarized with the data by a thorough (re)reading from the data from the focus groups. Initial ideas that could possibly be of value will be noted down. The second phase consists of the coding process, where interesting features in the data are being labeled and initial codes will be produced. An interpretative analysis of the data occurs and similarities in the codes will be identified, generating potential themes. These themes will be discussed within the research team and further refined in the next phase, where clear definitions and names will be generated. The analysis will be carried out by the corresponding researcher from each test-site. This in order to enable a focus on the different perspectives resulting from the different settings where the study will be conducted.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ghent, Belgium, 9000
- Ghent University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 65+
- Score range of 19/30 - 25/30 on Montreal Cognitive Assessment (MoCA)
- Ability to walk independently with or without assistive device
Exclusion Criteria:
- Health conditions that do not allow participation in a physical intervention
- Planned surgery or hospitalisation within 12 months of the trial
- Insufficient language skills
- History of severe neurological (e.g. stroke) or psychiatric (e.g. depression) condition
- Severe vision impairment / hearing loss
- Participation in another study to test a new technology
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Older adults with MCI
|
The intervention group will work with the ReMIND-system. This ReMIND-system consists of:
|
Active Comparator: Caregivers
|
The intervention group will work with the ReMIND-system. This ReMIND-system consists of:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Active Engagement at month 6
Time Frame: baseline, month 6
|
Active engagement will be assessed using a time-sampling method.
A scoring form will be adapted based on a protocol called 'Video Coding Incorporating Observed Emotion' (VC-IOE).
|
baseline, month 6
|
Change from baseline Loneliness at month 6
Time Frame: baseline, month 6
|
Loneliness will be assessed by De Jong-Gierveld 11-item Loneliness Scale. Scores range between 0-11 points, with a higher score indicating stronger feelings of loneliness. Score 0-2: not lonely, score 3-11: lonely. Within the lonely people, a distinction can be made between moderate lonely people (scoring 3 to 8) and strong lonely people (scoring 9 to 11). The instrument is divided into two subscales: emotional and social loneliness. Social loneliness occurs when someone is missing a wider social network. Emotional loneliness refers to missing an "intimate" relationship or friendship. |
baseline, month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Physical functioning at month 6
Time Frame: baseline, month 6
|
Physical functioning will be assessed using the Short Physical Performance Battery (SPPB).
A summary score of 0 to 12 (higher score indicating better function) is based on performance on three tasks: gait speed, chair rise, and three standing positions.
|
baseline, month 6
|
Change from baseline Cognitive functioning at month 6
Time Frame: baseline, month 6
|
The Montreal Cognitive Assessment (MoCA) will be applied to measure cognitive functioning.
Scores range between 0-30, with a higher score indicating a better cognitive functioning.
|
baseline, month 6
|
Change from baseline Participation level at month 6
Time Frame: baseline, month 6
|
Single-item measures were created to question the participant's level of participation.
Participants have to indicate on a scale from 0-10 to what extent they agree with the propositions.
|
baseline, month 6
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B6702020000244
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Meir Medical CenterTerminatedMild Cognitive Impairment (MCI)Israel
Clinical Trials on socially assistive robot
-
Vanderbilt UniversityNational Institute on Aging (NIA)RecruitingAlzheimer DiseaseUnited States
-
University of California, Los AngelesUniversity of Southern CaliforniaRecruiting
-
Assistance Publique - Hôpitaux de ParisUniversità degli Studi di Trento; Institut National de Recherche en Informatique... and other collaboratorsRecruitingPatient Participation | Professional Role | Patient Relations, NurseFrance
-
University of BedfordshireÖrebro University, Sweden; Nagoya University; Università degli Studi of Genova; Middlesex University and other collaboratorsUnknown
-
Tan Tock Seng HospitalNanyang Technological UniversityCompletedStroke | Spinal Cord Injuries | Acquired Brain Injury | Traumatic Brain Injury With Loss of Consciousness | Joint Replacement SurgerySingapore
-
UConn HealthNational Institutes of Health (NIH); National Institute on Aging (NIA)RecruitingParkinson DiseaseUnited States
-
University of British ColumbiaCompleted
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingCoronary Artery Disease | Ischemic Heart Disease | Congestive Heart Failure | Acute Myocardial Infarction
-
Yale UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Riphah International UniversityCompletedPneumonia ChildhoodPakistan